One of the pioneering companies developing pharmaceuticals and diagnostics based on the gut microbiome,...
Up To Date
Latest News
The long awaited global review on antimicrobial resistance by economist Lord Jim O’Neill has been published....
Bayer is deepening its involvement in CRISPR with a licensing agreement for genome editing patents. Irish...
Newly spun out company OxStem has raised £16.9m (€21.5m) to develop regenerative meds for the treatment of...
Swiss Genentech partner AC Immune has raised CHF42.7m (€38.6m) in order to advance its therapeutic and...
Ipsen is strengthening its ties to long-time development partner Oncodesign, a Dijon-based cancer treatment...